Supernus Pharmaceuticals (SUPN) Change in Inventory (2016 - 2026)
Supernus Pharmaceuticals has reported Change in Inventory over the past 14 years, most recently at $4.2 million for Q4 2025.
- Quarterly Change in Inventory rose 231.16% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 147.46% year-over-year, with the annual reading at $7.5 million for FY2025, 147.46% up from the prior year.
- Change in Inventory was $4.2 million for Q4 2025 at Supernus Pharmaceuticals, down from $12.9 million in the prior quarter.
- Over five years, Change in Inventory peaked at $12.9 million in Q3 2025 and troughed at -$6.9 million in Q3 2023.
- The 5-year median for Change in Inventory is $1.2 million (2021), against an average of $901200.0.
- Year-over-year, Change in Inventory surged 2606.67% in 2021 and then crashed 251.42% in 2024.
- A 5-year view of Change in Inventory shows it stood at $5.2 million in 2021, then skyrocketed by 120.12% to $11.6 million in 2022, then crashed by 143.52% to -$5.0 million in 2023, then soared by 36.61% to -$3.2 million in 2024, then skyrocketed by 231.16% to $4.2 million in 2025.
- Per Business Quant, the three most recent readings for SUPN's Change in Inventory are $4.2 million (Q4 2025), $12.9 million (Q3 2025), and -$4.9 million (Q2 2025).